IPM514

· Peking University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IPM514, covering 2024-11-15 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma. [Phase 1]